Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Director/PDMR Shareholding

16 Nov 2005 15:40

Synairgen plc16 November 2005 Synairgen plc ("Synairgen" or the "Company") Director Shareholdings The Company was informed on 15 November 2005 that Richard Marsden, ManagingDirector of Synairgen, had been granted options on 15 November 2005 over 43,829ordinary shares of 1 pence each ("Ordinary Shares") in the Company under theCompany's Long-Term Incentive Plan (the "LTIP") at an exercise price of 1 pence. Mr Marsden's holding in options over Ordinary Shares has therefore increased to743,829, representing approximately 3.43 per cent. of the issued ordinary sharecapital of the Company. The Company was informed on 15 November 2005 that John Ward, Finance Director ofSynairgen, had been granted options on 15 November 2005 over 105,191 OrdinaryShares in the Company under the Company's LTIP at an exercise price of 1 pence. Mr Ward's holding in options over Ordinary Shares has therefore increased to385,191, representing approximately 1.78 per cent. of the issued ordinary sharecapital of the Company. This information is provided by RNS The company news service from the London Stock Exchange

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.